Nitrogen Dioxide in the Sensitization to Allergic Airway Disease
Nitrogen Dioxide in the Sensitization to Allergic Airway Disease
批准号:
7474734
负责人:
Matthew E Poynter
金额:
$37.65万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-08-01 至 2012-04-30
关键词:
Acute Lung InjuryAdaptor Signaling ProteinAir PollutionAllergicAlveolarAntigensAsthmaBone MarrowBreathingCCL20 geneCD4 Positive T LymphocytesCellsChildDendritic CellsDevelopmentEosinophiliaEpithelialEpithelial CellsEpitheliumExposure toExtrinsic asthmaFigs - dietaryFree RadicalsFunctional disorderGasesGene ExpressionGenerationsHealthHelper-Inducer T-LymphocyteHematopoieticHypersensitivityIgEImmuneImmune responseImmunoglobulin GIncidenceIndividualInflammationInflammatoryInterleukin-12Interleukin-6LifeLungMeasuresMetaplasiaModelingMolecularMucous body substanceMusNF-kappa BNecrosisNitrogen DioxideOvalbuminOxidantsProcessProteinsResearch PersonnelRiskSerumSignal PathwaySignal TransductionTLR2 geneTLR4 geneTestingToll-Like Receptor 2Toll-like receptorsVirus DiseasesWheezingairway hyperresponsivenessallergic airway diseasechemokinecytokinemembermouse modelnovelpollutantprogramsrespiratorytranscription factoruptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The incidence of allergic asthma has risen steadily over the last 20 years and now represents an enormous health and financial burden. Reasons for this rise remain unclear, but increases in ambient pollutant levels, including the toxic free radical gas, nitrogen dioxide (NO2), correlate with the incidence of allergy and asthma. Additionally, children with severe respiratory viral infections, in which NO2 is generated endogenously, are at an elevated risk of developing asthma later in life. However, the molecular mechanisms by which NO2 exposure may facilitate allergic sensitization, leading to the development of allergic airway disease remains unknown. Elucidating these mechanisms is the subject of this proposal. Certain endogenous molecules, including components of the debris released from necrotic cells, may be immunostimulatory by signaling through Toll-Like Receptor (TLR)2 or TLR4, leading to intracellular signaling involving the adaptor protein, MyD88, and activation of the transcription factor, NF-kappaB. In pulmonary epithelial cells, NF-kappaB modulates expression of CCL20, which promotes the recruitment of dendritic cells (DCs) to the lungs. DCs induce adaptive immune responses by stimulating T helper cells in an antigen- specific manner and may polarize them towards Th2, steps necessary to confer sensitization to allergic airway disease. The central hypothesis of this proposal is that NO2 exposure facilitates the sensitization to inhaled antigen through the stimulation of pulmonary epithelial TLR2 orTLR4, MyD88, and NF-kappaB, promoting dendritic cell recruitment and maturation. This hypothesis will be tested in three specific aims in which allergic sensitization and the generation of cardinal features of allergic airway disease will be measured in mice deficient (TLR2, TLR4 or MyD88) or inhibited (airway and/or alveolar type 2 epithelial NF-kappaB) in members of these signaling pathways, as well as in bone marrow chimeric mice, in order to distinguish the importance of these molecules in cells of hematopoietic origin (DCs) versus structural lung cells (epithelium).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Ketone Body Supplementation in Obese Asthma
-
批准号:9905425
-
项目类别:
-
资助金额:$44.56万
-
财政年份:2018
-
负责人:Matthew E Poynter
-
依托单位:
Serum Amyloid A3 in Allergic Asthma: An Endogenous Mediator of Disease Severity
-
批准号:8290627
-
项目类别:
-
资助金额:$38.13万
-
财政年份:2012
-
负责人:Matthew E Poynter
-
依托单位:
Serum Amyloid A3 in Allergic Asthma: An Endogenous Mediator of Disease Severity
-
批准号:8616089
-
项目类别:
-
资助金额:$37.36万
-
财政年份:2012
-
负责人:Matthew E Poynter
-
依托单位:
Serum Amyloid A3 in Allergic Asthma: An Endogenous Mediator of Disease Severity
-
批准号:8802887
-
项目类别:
-
资助金额:$37.55万
-
财政年份:2012
-
负责人:Matthew E Poynter
-
依托单位:
Serum Amyloid A3 in Allergic Asthma: An Endogenous Mediator of Disease Severity
-
批准号:8451381
-
项目类别:
-
资助金额:$36.3万
-
财政年份:2012
-
负责人:Matthew E Poynter
-
依托单位:
Nitrogen Dioxide in the Sensitization to Allergic Airway Disease
-
批准号:7839235
-
项目类别:
-
资助金额:$27.08万
-
财政年份:2009
-
负责人:Matthew E Poynter
-
依托单位:
MECHANISMS OF ALLERGIC SENSITIZATION BY NITROGEN DIOXIDE EXPOSURE
-
批准号:7720874
-
项目类别:
-
资助金额:$23.86万
-
财政年份:2008
-
负责人:Matthew E Poynter
-
依托单位:
Nitrogen Dioxide in the Sensitization to Allergic Airway Disease
-
批准号:7808774
-
项目类别:
-
资助金额:$37.63万
-
财政年份:2007
-
负责人:Matthew E Poynter
-
依托单位:
Nitrogen Dioxide in the Sensitization to Allergic Airway Disease
-
批准号:7296585
-
项目类别:
-
资助金额:$37.75万
-
财政年份:2007
-
负责人:Matthew E Poynter
-
依托单位:
MECHANISMS OF ALLERGIC SENSITIZATION BY NITROGEN DIOXIDE EXPOSURE
-
批准号:7609698
-
项目类别:
-
资助金额:$27.57万
-
财政年份:2007
-
负责人:Matthew E Poynter
-
依托单位:
Nitrogen Dioxide in the Sensitization to Allergic Airway Disease
-
批准号:7595837
-
项目类别:
-
资助金额:$37.63万
-
财政年份:2007
-
负责人:Matthew E Poynter
-
依托单位:
Nitrogen Dioxide in the Sensitization to Allergic Airway Disease
-
批准号:8071539
-
项目类别:
-
资助金额:$37.63万
-
财政年份:2007
-
负责人:Matthew E Poynter
-
依托单位:
MECHANISMS OF ALLERGIC SENSITIZATION BY NITROGEN DIOXIDE EXPOSURE
-
批准号:7381076
-
项目类别:
-
资助金额:$29.72万
-
财政年份:2006
-
负责人:Matthew E Poynter
-
依托单位:
COBRE: UVT: AIRWAY SIGNALING CASCADES NITROGEN DIOXIDE
-
批准号:7170234
-
项目类别:
-
资助金额:$23.9万
-
财政年份:2005
-
负责人:Matthew E Poynter
-
依托单位:
COBRE: UVT: AIRWAY EPITHELIAL SIGNALING CASCADES EVOKED BY NITROGEN DIOXIDE
-
批准号:7011651
-
项目类别:
-
资助金额:$29.9万
-
财政年份:2004
-
负责人:Matthew E Poynter
-
依托单位:
Airway Epithelial NF-kB Activation by CpG DNA
-
批准号:6477811
-
项目类别:
-
资助金额:$10.8万
-
财政年份:2003
-
负责人:Matthew E Poynter
-
依托单位:
Airway Epithelial NF-kB Activation by CpG DNA
-
批准号:6895941
-
项目类别:
-
资助金额:$10.8万
-
财政年份:2003
-
负责人:Matthew E Poynter
-
依托单位:
Airway Epithelial NF-kB Activation by CpG DNA
-
批准号:6801113
-
项目类别:
-
资助金额:$10.8万
-
财政年份:2003
-
负责人:Matthew E Poynter
-
依托单位:
NF-KB ACTIVATION BY BRONCHIOLAR EPITHELIUM IN ASTHMA
-
批准号:6453572
-
项目类别:
-
资助金额:$4.02万
-
财政年份:2001
-
负责人:Matthew E Poynter
-
依托单位:
NF-KB ACTIVATION BY BRONCHIOLAR EPITHELIUM IN ASTHMA
-
批准号:6140051
-
项目类别:
-
资助金额:$3.04万
-
财政年份:2000
-
负责人:Matthew E Poynter
-
依托单位: